January 12, 2010 – In its January issue, Prevention magazine named the Endo-PAT2000 endothelial function testing device one of the top medical breakthroughs of 2009.
January 2, 2010 – The FDA cleared the Celsius RMT ThermoCool ablation catheter for use with Stereotaxis' magnetic navigation system in the treatment of type 1 atrial flutter.
January 11, 2010 – Health Canada, the Canadian equivalent of the U.S. FDA, cleared heart sound analysis software that connects wirelessly to a Bluetooth-enabled electronic stethoscope.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
January 11, 2010 – A hypertension drug using a combination of telmisartan/amlodipine, which requires less-frequent dosing than Novartis's Diovan/Tareg (valsartan), may earn 30 percent patient share according to surveyed U.S. cardiologists. Similarly, in Europe, the agent would earn comparable patient share of 25 percent according to surveyed European cardiologists.
January 11, 2010 – The first patients were enrolled in the phase 3 clinical trials for a drug designed to lower triglycerides for patients at risk for cardiovascular disease.
January 8, 2010 – Transradial angiography leads to reduced patient complications, faster recovery time and decreased hospital costs, according to cardiologists at the University of Illinois at Chicago (UIC) and Jesse Brown VA medical centers. They are among the first in the Chicago area to offer the new approach to heart angiograms and clearing blocked arteries.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
January 8, 2010 – Japanese regulatory officials this week cleared the XIENCE V Everolimus-Eluting Coronary Stent. Abbott said it plans to launch sales in Japan in the coming weeks, immediately following final reimbursement authorization.
January 7, 2010 – Doctors with Virginia Interventional and Vascular Associates (VIVA) report success in treating acute deep vein thrombosis (DVT) with a procedure called isolated pharmacomechanical thrombolysis (IPMT). The treatment has been used for the past two years to destroy clots much faster than traditional therapies.
January 7, 2010 – Anti-platelet treat with Effient (prasugrel) compared with Plavix (clopidogrel) was more cost effective, according to results from a health economic substudy of the TRITON-TIMI 38 trial. The trial looked at the drug treatments in patients with acute coronary syndromes (ACS) managed with percutaneous coronary intervention (PCI).
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
January 6, 2010 - The image quality of multidetector computed tomography (MDCT) scans used for the noninvasive detection of coronary artery disease can be significantly affected by patient characteristics, such as ethnicity, body mass index (BMI), and heart rate.
January 6, 2010 – European CE mark clearance was granted this week for the Volcano OCT (optical coherence tomography) imaging system and catheter. Volcano said its OCT system will be commercially available in Europe in early 2011.
January 6, 2010 – Two validation studies for a wireless, hand-held, patient-activated device that records and transmits reconstructed 12-lead ECGs confirmed the product's ability to accurately provide remote patient monitoring.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
January 6, 2010 – The FDA, in collaboration with major implantable pacemaker and implantable cardioverter-defibrillator (ICD) manufacturers, demonstrated the effects of emissions from radio frequency identification (RFID) readers on common implantable cardiac devices.
January 5, 2010 – In vivo and in vitro data released yesterday shows a new bioresorbable stent platform allows for complete endothelialization with little inflammation after one month.
January 5, 2010 – St. Paul’s Hospital in Vancouver, Canada recently was the first to use the Embrella Embolic Deflector cerebral protection system. The device uses a porous membrane to deflect emboli away from the carotid arteries. It is inserted through the right radial or right brachial artery, away from the femoral artery, which is the typical access site for procedures.